{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T21:29:10Z","timestamp":1781904550232,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Cancer Center Clinical Research in \u201cClimbing\u201d Foundation of China","award":["NCC201818A55"],"award-info":[{"award-number":["NCC201818A55"]}]},{"name":"Natural Science Foundation Health Union Foundation of Hunan Province, China","award":["2021JJ70030"],"award-info":[{"award-number":["2021JJ70030"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-16000-w","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:14:26Z","timestamp":1763633666000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Small cell size circulating tumor cells predict the prognosis of high-risk non-muscle invasive bladder cancer patients"],"prefix":"10.1038","volume":"15","author":[{"given":"Yuheng","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingji","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangwen","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqun","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"issue":"3","key":"16000_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74(3), 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"16000_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk, M. et al. European Association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ). Eur. Urol. 81(1), 75\u201394. https:\/\/doi.org\/10.1016\/j.eururo.2021.08.010 (2022).","journal-title":"Eur. Urol."},{"issue":"3","key":"16000_CR3","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester, R. J. et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur. Urol. 49(3), 466\u2013465. https:\/\/doi.org\/10.1016\/j.eururo.2005.12.031 (2006).","journal-title":"Eur. Urol."},{"issue":"7679","key":"16000_CR4","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1038\/551S34a","volume":"551","author":"C Berdik","year":"2017","unstructured":"Berdik, C. Unlocking bladder cancer. Nature 551(7679), S34-s35. https:\/\/doi.org\/10.1038\/551S34a (2017).","journal-title":"Nature"},{"issue":"6","key":"16000_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nrclinonc.2009.44","volume":"6","author":"K Pantel","year":"2009","unstructured":"Pantel, K., Alix-Panabi\u00e8res, C. & Riethdorf, S. Cancer micrometastases. Nat. Rev. Clin. Oncol. 6(6), 339\u2013351. https:\/\/doi.org\/10.1038\/nrclinonc.2009.44 (2009).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"16000_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1586\/14737159.2014.908119","volume":"14","author":"C Raimondi","year":"2014","unstructured":"Raimondi, C., Gradilone, A. & Gazzaniga, P. Circulating tumor cells in early bladder cancer: Insight into micrometastatic disease. Expert Rev. Mol. Diagn. 14(4), 407\u2013409. https:\/\/doi.org\/10.1586\/14737159.2014.908119 (2014).","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"7","key":"16000_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254433","volume":"16","author":"H Jiang","year":"2021","unstructured":"Jiang, H. et al. Prognostic value of circulating tumor cells in patients with bladder cancer: A meta-analysis. PLoS ONE 16(7), e0254433. https:\/\/doi.org\/10.1371\/journal.pone.0254433 (2021).","journal-title":"PLoS ONE"},{"issue":"8","key":"16000_CR8","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.ccell.2021.05.005","volume":"39","author":"KP Simeonov","year":"2021","unstructured":"Simeonov, K. P. et al. Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states. Cancer Cell 39(8), 1150-1162.e1159. https:\/\/doi.org\/10.1016\/j.ccell.2021.05.005 (2021).","journal-title":"Cancer Cell"},{"key":"16000_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.802188","volume":"11","author":"X Yang","year":"2021","unstructured":"Yang, X. et al. Clinical application of circulating tumor cells and circulating endothelial cells in predicting bladder cancer prognosis and neoadjuvant chemosensitivity. Front. Oncol. 11, 802188. https:\/\/doi.org\/10.3389\/fonc.2021.802188 (2021).","journal-title":"Front. Oncol."},{"issue":"29","key":"16000_CR10","doi-asserted-by":"publisher","first-page":"27049","DOI":"10.18632\/oncotarget.4819","volume":"6","author":"F Ge","year":"2015","unstructured":"Ge, F. et al. Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells. Oncotarget 6(29), 27049\u201327064. https:\/\/doi.org\/10.18632\/oncotarget.4819 (2015).","journal-title":"Oncotarget"},{"issue":"12","key":"16000_CR11","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1007\/s00432-019-03040-9","volume":"145","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. Vimentin expression in circulating tumor cells (CTCs) associated with liver metastases predicts poor progression-free survival in patients with advanced lung cancer. J. Cancer Res. Clin. Oncol. 145(12), 2911\u20132920. https:\/\/doi.org\/10.1007\/s00432-019-03040-9 (2019).","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"21","key":"16000_CR12","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1158\/1078-0432.Ccr-18-1205","volume":"24","author":"Y Li","year":"2018","unstructured":"Li, Y. et al. Evolutionary expression of HER2 conferred by chromosome aneuploidy on circulating gastric cancer cells contributes to developing targeted and chemotherapeutic resistance. Clin. Cancer Res. 24(21), 5261\u20135271. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-1205 (2018).","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"16000_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","volume":"69","author":"S Cambier","year":"2016","unstructured":"Cambier, S. et al. EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1\u20133 years of maintenance Bacillus Calmette-Gu\u00e9rin. Eur. Urol. 69(1), 60\u201369. https:\/\/doi.org\/10.1016\/j.eururo.2015.06.045 (2016).","journal-title":"Eur. Urol."},{"key":"16000_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ctrv.2018.03.007","volume":"66","author":"P Khetrapal","year":"2018","unstructured":"Khetrapal, P. et al. The role of circulating tumour cells and nucleic acids in blood for the detection of bladder cancer: A systematic review. Cancer Treat. Rev. 66, 56\u201363. https:\/\/doi.org\/10.1016\/j.ctrv.2018.03.007 (2018).","journal-title":"Cancer Treat. Rev."},{"issue":"2","key":"16000_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","volume":"21","author":"L Tran","year":"2021","unstructured":"Tran, L. et al. Advances in bladder cancer biology and therapy. Nat. Rev. Cancer 21(2), 104\u2013121. https:\/\/doi.org\/10.1038\/s41568-020-00313-1 (2021).","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"16000_CR16","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1038\/s41598-018-22126-x","volume":"8","author":"NA Marzouka","year":"2018","unstructured":"Marzouka, N. A. et al. A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort. Sci. Rep. 8(1), 3737. https:\/\/doi.org\/10.1038\/s41598-018-22126-x (2018).","journal-title":"Sci. Rep."},{"issue":"3","key":"16000_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.128","volume":"10","author":"Y Lei","year":"2020","unstructured":"Lei, Y. et al. Combined detection of aneuploid circulating tumor-derived endothelial cells and circulating tumor cells may improve diagnosis of early stage non-small-cell lung cancer. Clin. Transl. Med. 10(3), e128. https:\/\/doi.org\/10.1002\/ctm2.128 (2020).","journal-title":"Clin. Transl. Med."},{"issue":"9","key":"16000_CR18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrc3820","volume":"14","author":"C Alix-Panabi\u00e8res","year":"2014","unstructured":"Alix-Panabi\u00e8res, C. & Pantel, K. Challenges in circulating tumour cell research. Nat. Rev. Cancer 14(9), 623\u2013631. https:\/\/doi.org\/10.1038\/nrc3820 (2014).","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"16000_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.trecan.2015.07.006","volume":"1","author":"N Aceto","year":"2015","unstructured":"Aceto, N. et al. En route to metastasis: Circulating tumor cell clusters and epithelial-to-mesenchymal transition. Trends Cancer 1(1), 44\u201352. https:\/\/doi.org\/10.1016\/j.trecan.2015.07.006 (2015).","journal-title":"Trends Cancer"},{"key":"16000_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194817","author":"SR Ali","year":"2022","unstructured":"Ali, S. R. et al. Nerve density and neuronal biomarkers in cancer. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers14194817 (2022).","journal-title":"Cancers (Basel)"},{"key":"16000_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.590952","volume":"11","author":"Y Hong","year":"2021","unstructured":"Hong, Y. et al. Small cell size circulating aneuploid cells as a biomarker of prognosis in resectable non-small cell lung cancer. Front. Oncol. 11, 590952. https:\/\/doi.org\/10.3389\/fonc.2021.590952 (2021).","journal-title":"Front. Oncol."},{"key":"16000_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.canlet.2017.10.004","volume":"412","author":"L Wang","year":"2018","unstructured":"Wang, L. et al. Quantified postsurgical small cell size CTCs and EpCAM(+) circulating tumor stem cells with cytogenetic abnormalities in hepatocellular carcinoma patients determine cancer relapse. Cancer Lett. 412, 99\u2013107. https:\/\/doi.org\/10.1016\/j.canlet.2017.10.004 (2018).","journal-title":"Cancer Lett."},{"issue":"1","key":"16000_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3892\/ijo.2014.2409","volume":"45","author":"H Ito","year":"2014","unstructured":"Ito, H. et al. Prognostic impact of the number of viable circulating cells with high telomerase activity in gastric cancer patients: a prospective study. Int. J. Oncol. 45(1), 227\u2013234. https:\/\/doi.org\/10.3892\/ijo.2014.2409 (2014).","journal-title":"Int. J. Oncol."},{"issue":"4","key":"16000_CR24","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1080\/15384047.2018.1538000","volume":"20","author":"Z Ye","year":"2019","unstructured":"Ye, Z. et al. Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies. Cancer Biol. Ther. 20(4), 546\u2013551. https:\/\/doi.org\/10.1080\/15384047.2018.1538000 (2019).","journal-title":"Cancer Biol. Ther."},{"issue":"8","key":"16000_CR25","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1101\/gad.277681.116","volume":"30","author":"T Celia-Terrassa","year":"2016","unstructured":"Celia-Terrassa, T. & Kang, Y. Distinctive properties of metastasis-initiating cells. Genes Dev. 30(8), 892\u2013908. https:\/\/doi.org\/10.1101\/gad.277681.116 (2016).","journal-title":"Genes Dev."},{"issue":"7","key":"16000_CR26","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nmeth.3404","volume":"12","author":"AF Sarioglu","year":"2015","unstructured":"Sarioglu, A. F. et al. A microfluidic device for label-free, physical capture of circulating tumor cell clusters. Nat. Methods 12(7), 685\u2013691. https:\/\/doi.org\/10.1038\/nmeth.3404 (2015).","journal-title":"Nat. Methods"},{"issue":"5","key":"16000_CR27","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","volume":"158","author":"N Aceto","year":"2014","unstructured":"Aceto, N. et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158(5), 1110\u20131122. https:\/\/doi.org\/10.1016\/j.cell.2014.07.013 (2014).","journal-title":"Cell"},{"key":"16000_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics8020026","author":"PP Lin","year":"2018","unstructured":"Lin, P. P. Aneuploid CTC and CEC. Diagnostics (Basel) https:\/\/doi.org\/10.3390\/diagnostics8020026 (2018).","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"16000_CR29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41576-019-0171-x","volume":"21","author":"U Ben-David","year":"2020","unstructured":"Ben-David, U. & Amon, A. Context is everything: Aneuploidy in cancer. Nat. Rev. Genet. 21(1), 44\u201362. https:\/\/doi.org\/10.1038\/s41576-019-0171-x (2020).","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"16000_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.trecan.2021.09.002","volume":"8","author":"DA Lukow","year":"2022","unstructured":"Lukow, D. A. & Sheltzer, J. M. Chromosomal instability and aneuploidy as causes of cancer drug resistance. Trends Cancer 8(1), 43\u201353. https:\/\/doi.org\/10.1016\/j.trecan.2021.09.002 (2022).","journal-title":"Trends Cancer"},{"key":"16000_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.821454","volume":"12","author":"B Hu","year":"2022","unstructured":"Hu, B. et al. Comprehensive atlas of circulating rare cells detected by SE-iFISH and image scanning platform in patients with various diseases. Front. Oncol. 12, 821454. https:\/\/doi.org\/10.3389\/fonc.2022.821454 (2022).","journal-title":"Front. Oncol."},{"issue":"1","key":"16000_CR32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40169-015-0081-2","volume":"4","author":"PP Lin","year":"2015","unstructured":"Lin, P. P. Integrated EpCAM-independent subtraction enrichment and iFISH strategies to detect and classify disseminated and circulating tumors cells. Clin. Transl. Med. 4(1), 38. https:\/\/doi.org\/10.1186\/s40169-015-0081-2 (2015).","journal-title":"Clin. Transl. Med."},{"issue":"7745","key":"16000_CR33","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-019-0915-y","volume":"566","author":"BM Szczerba","year":"2019","unstructured":"Szczerba, B. M. et al. Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature 566(7745), 553\u2013557. https:\/\/doi.org\/10.1038\/s41586-019-0915-y (2019).","journal-title":"Nature"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16000-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16000-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16000-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:14:26Z","timestamp":1763633666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16000-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16000"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16000-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee) of Hunan Cancer Hospital (IRB number: KYJJ-2023-127).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Informed consent was obtained from all subjects involved in the study. Written informed consent has been obtained from the patients to publish this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"40909"}}